Fostering Rare Cancer Drug Development
The TargetCancer Foundation Industry Roundtable is a bi-annual invitation-only meeting that unites partners in the rare cancer and tissue-agnostic drug development spaces. This highly interactive, discussion-based meeting allows companies to discuss common challenges and opportunities for collaboration. In addition, key research, clinical, regulatory, and other stakeholders from the TargetCancer Foundation community attend and provide their perspectives. The initiatives generated through these action-oriented meetings are developed and led by TargetCancer Foundation.
2024 Industry Roundtable
Our third Industry Roundtable took place in November 2024, inspiring a vibrant, ongoing conversation about rare cancer and tissue-agnostic drug development.
Thank You to Our 2024 Industry Roundtable Participating Companies:
